Swiss Venture Capital Report 2018 Highlights Presentation (Swiss Venture Capital Report (startupticker))

Summary

• In 2017, Swiss startups received total venture capital funding of CHF 938 million.p.1
• ADC Therapeutics secured the largest single financing round amounting to CHF 196.8 million.p.4
• A total of 101 start-ups disclosed financial numbers, representing 58% of the total 175 start-ups.p.11
• Startups outside of Vaud experienced venture capital growth of 43%.p.15
• 79 companies out of 175 had at least one woman in top management or on the board, attracting 76% of total invested sum.p.16
• 10 companies with a female CEO attracted 2% of total invested sum.p.16
• Symetis recorded a major exit after being sold for $435 million.p.17

Key insights

1. Swiss startups raised CHF 938 million in venture capital during 2017.p.1
2. Biotech capital rounds increased steadily while Fintech reached investment parity with medtech.p.7
3. The median financing amount for early stage rounds stood at CHF 2.0m.p.9
4. Financing rounds between ≥ 1m and < CHF 5m represented 41 of the 101 disclosed transactions.p.11
5. Investment growth outside the canton of Vaud reached 43%.p.15
6. Companies with women in top management or on the board secured 76% of all invested capital.p.16
7. Female-led startups with a female CEO captured 2% of the total invested capital.p.16
8. Symetis achieved a significant exit transaction valued at $435 million.p.17